Asian shares wobble amid trade, geopolitical tensions; focus on Fed meeting
June 17, 2019
Huawei says U.S. ban hurting more than expected, to wipe $30 billion off revenue
June 17, 2019

Pfizer to buy cancer drug developer Array for $10.64 billion

Pfizer Inc said on Monday it would acquire Array Biopharma Inc for $10.64 billion in cash, giving it access to the target’s approved drugs for skin cancer and the targeted cancer medicines in its pipeline.

Powered by WPeMatico